Disparity in use of modern combination chemotherapy associated with facility type influences survival of 2655 patients with advanced pancreatic cancer

Morten Ladekarl^*, Louise Skau Rasmussen, Jakob Kirkegård, Inna Chen, Per Pfeiffer, Britta Weber, Halla Skuladottir, Kell Østerlind, Jim Stenfatt Larsen, Frank Viborg Mortensen, Henriette Engberg, Henrik Møller, Claus Wilki Fristrup

^*Kontaktforfatter

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

4 Citationer (Scopus)

29 Downloads (Pure)

1 resultater
- Titel(faldende)
- Startdato

Disparity in use of modern combination chemotherapy associated with facility type influences survival of 2655 patients with advanced pancreatic cancer
Ladekarl, M. (Ophavsperson), Rasmussen, L. S. (Ophavsperson), Kirkegård, J. (Ophavsperson), Chen, I. (Ophavsperson), Pfeiffer, P. (Ophavsperson), Weber, B. (Ophavsperson), Skuladottir, H. (Ophavsperson), Østerlind, K. (Ophavsperson), Larsen, J. S. (Ophavsperson), Mortensen, F. V. (Ophavsperson), Engberg, H. (Ophavsperson), Møller, H. (Ophavsperson) & Fristrup, C. W. (Ophavsperson), Taylor & Francis, 2021
DOI: 10.6084/m9.figshare.17150821.v1, https://tandf.figshare.com/articles/journal_contribution/Disparity_in_use_of_modern_combination_chemotherapy_associated_with_facility_type_influences_survival_of_2655_patients_with_advanced_pancreatic_cancer/17150821/1
Datasæt